Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 430
Filter
1.
Cardiac sarcomere turnover by unidirectional replacement of proteins.
Lim, Gregory B.
Nat Rev Cardiol ; 2024 Jul 22.
Article in English | MEDLINE | ID: mdl-39039179
2.
RNA interference lowers triglyceride levels.
Lim, Gregory B.
Nat Rev Cardiol ; 21(8): 522, 2024 08.
Article in English | MEDLINE | ID: mdl-38849676

Subject(s)
Triglycerides , Humans , Triglycerides/blood , RNA Interference , Hypertriglyceridemia/blood , Hypertriglyceridemia/therapy , Hypertriglyceridemia/genetics , Animals
3.
No benefit of apoA-I infusion after myocardial infarction.
Lim, Gregory B.
Nat Rev Cardiol ; 21(6): 354, 2024 06.
Article in English | MEDLINE | ID: mdl-38702389

Subject(s)
Apolipoprotein A-I , Myocardial Infarction , Humans , Myocardial Infarction/drug therapy , Treatment Outcome , Infusions, Intravenous
4.
Aficamten reduces symptoms in obstructive hypertrophic cardiomyopathy.
Lim, Gregory B.
Nat Rev Cardiol ; 21(7): 437, 2024 07.
Article in English | MEDLINE | ID: mdl-38806635

Subject(s)
Cardiomyopathy, Hypertrophic , Humans , Cardiomyopathy, Hypertrophic/physiopathology , Cardiomyopathy, Hypertrophic/drug therapy , Cardiomyopathy, Hypertrophic/complications , Treatment Outcome , Benzylamines , Uracil/analogs & derivatives
5.
No benefit of ß-blockers after myocardial infarction with preserved ejection fraction.
Lim, Gregory B.
Nat Rev Cardiol ; 21(6): 354, 2024 06.
Article in English | MEDLINE | ID: mdl-38649758

Subject(s)
Adrenergic beta-Antagonists , Myocardial Infarction , Stroke Volume , Humans , Adrenergic beta-Antagonists/therapeutic use , Stroke Volume/drug effects , Myocardial Infarction/drug therapy , Myocardial Infarction/physiopathology , Treatment Outcome
6.
Benefits of ninerafaxstat in non-obstructive hypertrophic cardiomyopathy.
Lim, Gregory B.
Nat Rev Cardiol ; 21(6): 357, 2024 06.
Article in English | MEDLINE | ID: mdl-38654087

Subject(s)
Cardiomyopathy, Hypertrophic , Humans , Cardiomyopathy, Hypertrophic/drug therapy , Cardiomyopathy, Hypertrophic/physiopathology , Cardiomyopathy, Hypertrophic/complications , Treatment Outcome , Benzylamines , Uracil/analogs & derivatives
7.
Periodontal treatment reduces AF recurrence.
Lim, Gregory B.
Nat Rev Cardiol ; 21(6): 355, 2024 06.
Article in English | MEDLINE | ID: mdl-38664574

Subject(s)
Atrial Fibrillation , Humans , Atrial Fibrillation/therapy , Atrial Fibrillation/physiopathology , Recurrence , Periodontal Diseases/therapy , Secondary Prevention/methods , Treatment Outcome
8.
Metabolic product of excess niacin is linked to increased risk of cardiovascular events.
Lim, Gregory B.
Nat Rev Cardiol ; 21(5): 280, 2024 05.
Article in English | MEDLINE | ID: mdl-38438588

Subject(s)
Cardiovascular Diseases , Hydroxymethylglutaryl-CoA Reductase Inhibitors , Niacin , Humans , Niacin/adverse effects , Hypolipidemic Agents/adverse effects , Cardiovascular Diseases/epidemiology , Cardiovascular Diseases/chemically induced
9.
Weight loss from surgery or drug therapy reduces blood pressure.
Lim, Gregory B.
Nat Rev Cardiol ; 21(4): 218, 2024 04.
Article in English | MEDLINE | ID: mdl-38374340

Subject(s)
Hypertension , Weight Loss , Humans , Blood Pressure , Weight Loss/physiology , Obesity , Hypertension/drug therapy
10.
Fibroblast-like cells promote plaque stability in response to anti-IL-1ß therapy.
Lim, Gregory B.
Nat Rev Cardiol ; 21(3): 155, 2024 03.
Article in English | MEDLINE | ID: mdl-38263457

Subject(s)
Fibroblasts , Humans , Interleukin-1beta
11.
Levothyroxine supplementation does not improve heart transplantation from brain-dead donors.
Lim, Gregory B.
Nat Rev Cardiol ; 21(2): 74, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38066088

Subject(s)
Heart Transplantation , Thyroxine , Humans , Thyroxine/therapeutic use , Tissue Donors , Brain Death , Brain , Dietary Supplements
12.
Aspirin exclusion in patients with an LVAD.
Lim, Gregory B.
Nat Rev Cardiol ; 21(2): 72, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38012304

Subject(s)
Heart Failure , Heart-Assist Devices , Humans , Aspirin/therapeutic use , Platelet Aggregation Inhibitors/therapeutic use , Retrospective Studies
13.
PCI for stable angina.
Lim, Gregory B.
Nat Rev Cardiol ; 21(2): 71, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38036671

Subject(s)
Angina, Stable , Percutaneous Coronary Intervention , Humans , Angina, Stable/surgery , Percutaneous Coronary Intervention/adverse effects , Quality of Life , Treatment Outcome
14.
Explaining how a cardiac reflex causes syncope.
Lim, Gregory B.
Nat Rev Cardiol ; 21(1): 9, 2024 01.
Article in English | MEDLINE | ID: mdl-37964079

Subject(s)
Heart , Syncope , Humans , Syncope/diagnosis , Syncope/etiology , Reflex
15.
Revealing the structure of the cardiac myosin filament.
Lim, Gregory B.
Nat Rev Cardiol ; 21(1): 7, 2024 01.
Article in English | MEDLINE | ID: mdl-37964080

Subject(s)
Cardiac Myosins , Myocardium , Humans , Cardiac Myosins/genetics , Cardiac Myosins/analysis , Cardiac Myosins/chemistry , Heart
16.
SARS-CoV-2 infects macrophages in coronary atherosclerotic plaques.
Lim, Gregory B.
Nat Rev Cardiol ; 20(12): 797, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37853160

Subject(s)
COVID-19 , Coronary Artery Disease , Plaque, Atherosclerotic , Humans , SARS-CoV-2 , Macrophages , Coronary Vessels
17.
No benefit of colchicine to prevent AF or myocardial injury after non-cardiac surgery.
Lim, Gregory B.
Nat Rev Cardiol ; 20(11): 719, 2023 Nov.
Article in English | MEDLINE | ID: mdl-37666904
18.
VA-ECMO does not increase survival in MI-related cardiogenic shock.
Lim, Gregory B.
Nat Rev Cardiol ; 20(11): 720, 2023 Nov.
Article in English | MEDLINE | ID: mdl-37674058
19.
Cholesterol catabolism and bile acid synthesis in cardiomyocytes promote inflammation and heart failure.
Lim, Gregory B.
Nat Rev Cardiol ; 20(10): 647, 2023 10.
Article in English | MEDLINE | ID: mdl-37524809

Subject(s)
Heart Failure , Myocytes, Cardiac , Humans , Myocytes, Cardiac/metabolism , Bile Acids and Salts , Cholesterol/metabolism , Inflammation
20.
Testosterone-replacement therapy does not increase cardiac events in men with hypogonadism.
Lim, Gregory B.
Nat Rev Cardiol ; 20(9): 581, 2023 09.
Article in English | MEDLINE | ID: mdl-37391471

Subject(s)
Cardiovascular Diseases , Hypogonadism , Male , Humans , Hypogonadism/drug therapy , Testosterone/adverse effects
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL